Posts Tagged ‘prostate cancer drugs’

URO TODAY: Researchers in Canada have reviewed the vast range of drugs now being used to treatment prostate cancer. These include:

  • drugs that induce androgen deprivation, that is, LHRH antagonists;
  • more active or less toxic chemotherapy agents;
  • immunologic approaches, including passive and active immunization;
  • drugs that target the androgen receptor and/or androgen synthesis;
  • drugs that target specific pathways, including tyrosine kinase inhibitors, angiogenesis inhibitors, endothelin antagonists and matrix metalloproteinase inhibitors;
  • and antioxidants and cell cycle inhibitors.

READ MORE> (but note, you need to subscribe – that is, pay – to see the article).

Read Full Post »

MAY 14: MEMPHIS DAILY NEWS:  Memphis company GTx expects to receive approval from the US Food and Drug Administration on Octopber 30 to begin selling a drug to prevent bone fractures in men undergoing hormone therapy to treat bone cancer. The company also has other drugs in the pipeline related to the prevention and treatment of prostate cancer and to build body mass in people with cancer-induced muscle loss. READ MORE>

Read Full Post »